Hematology Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global Hematology Analyzers Market has witnessed substantial growth, with revenues reaching approximately US$ 1.43 Billion in 2024. The market is expected to experience a steady Compound Annual Growth Rate (CAGR) of 6%, reaching a valuation of approximately US$ 2.15 Billion by the end of 2031. Several factors are contributing to the growth of the Hematology Analyzers Market.

Advanced Hematology Analyzers Enhance Diagnostic Accuracy

The introduction of advanced hematology analyzers, offering both quantitative and qualitative data, including suspicious flags for error detection, has significantly improved diagnostic capabilities. Access to real-time graphical data has proven to be more effective, providing insights into aberrant cell populations and disease patterns. This technical advancement has led to a broader adoption of hematological analyzers on a global scale.

Research and Development Drive Market Growth

Continuously expanding research and development efforts in fields such as stem cell research, gene therapies, targeted therapies, blood disorders, thalassemia, and omics are contributing to the rapid growth of the global Hematology Analyzers Market. The market is thriving due to increased public awareness and the presence of numerous diagnostic facilities.

Innovation and Technological Advancements Boost Sales

Leading manufacturers are focusing on innovation-based approaches, harnessing opportunities for scientific development in diagnostics and testing. The introduction of new technological advancements and the development of cellular analysis software have improved the efficiency of analysis and data management, resulting in increased sales.

Rising Chronic Disease Awareness Drives Market Growth

The growing awareness of chronic diseases worldwide is a significant driver of market growth. Chronic diseases are a leading cause of death and illness globally, affecting individuals across all socioeconomic classes. In the coming years, more individuals are expected to use hematology analyzers for early disease diagnosis and treatment to slow down disease progression rates.

Factors Driving Market Growth:

1. Increasing Cases of Blood Disorders in Infants and Constant Product Innovation: Blood analysis has gained popularity for the early diagnosis of chronic diseases, leading to significant growth in the Hematology Analyzers Market. Constant product innovation and the adoption of automated and AI-based analyzers are contributing to market expansion.

2. High Sensitivity Hematology Testing and Automation: The growing adoption of automated hematology analyzers and the integration of AI-based technology, coupled with the preference for high sensitivity hematology testing, are driving market growth.

3. Product Innovation and Commercialization: Automation has led to the development of new instruments and systems, such as automated erythrocyte sedimentation rate (ESR) systems, tube sorters, and electronic morphology systems, further fueling market demand.

Factors Affecting Market Growth:

1. High Product Costs and Stringent Regulatory Environment: The high cost of hematology analyzers and stringent regulatory standards can limit market growth, particularly in underdeveloped countries.

2. Product Recalls and Safety Concerns: Product recalls and concerns about product safety and efficacy can affect market growth by reducing consumer trust and adoption.

Why is the United States Market Booming?

The United States is expected to dominate the market in terms of revenue due to the increasing prevalence of blood disorders, such as anemia, and the adoption of hematology analyzers in the diagnostic sector. Technological advancements in diagnostic instruments further contribute to market expansion.

Will the U.K. Be a Lucrative Market for Hematology Analyzers?

The United Kingdom is expected to experience market expansion due to a strong emphasis on research and development activities, constant product development and innovation, the presence of established players, and high government expenditures.

How is China Emerging as a Prominent Market?

China's market growth is driven by the rising frequency of thalassemia in the general population, increasing adoption rates of automated hematology instruments, and growing demand for high sensitivity point-of-care (POC) hematology testing.

Competitive Landscape:

Market players are heavily invested in developing novel products, introducing features like 3D scatter maps and suspect mapping. Partnerships with distributors are also a key focus area to enhance product penetration globally.

Key Companies Profiled:

SYSMEX CORPORATION
Abbott Laboratories
Beckman Coulter Inc.
Siemens AG
Boule Diagnostics AB
Nihon Kohden Corporation
Mindray
HORIBA Ltd.
Diatron
Cellavision
Edan Instruments, Inc
SAMSUNG
Biosystems SA
F. Hoffmann-La Roche Ltd.
Shenzhen Dymind Biotechnology Co. Ltd.
PZ CORMAY SA
PixCell
Shenzhen Landwind Industry Co. Ltd.
Rayto Life and Analytical Sciences Co. Ltd
Shenzen Prokan Electronics Inc.

Market Segmentation

Product:

3-Part
5-Part
Others

Modality:

Standalone
Point of Care

End User:

Hospitals
Diagnostic Centers
Ambulatory Surgical Centers
Blood Banks

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Hematology Analyzers Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

3.1. Global Hematology Analyzers Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2023
- 3.1.1. North America
- 3.1.2. Europe
- 3.1.3. Asia Pacific
- 3.1.4. Latin America
- 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
4.2. Prominent Factor Affecting Hematology Analyzers Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Hematology Analyzers Market Outlook, 2018 - 2031

5.1. Global Hematology Analyzers Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. 3-Part
  - 5.1.1.2. 5-Part
  - 5.1.1.3. Others
5.2. Global Hematology Analyzers Market Outlook, by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Standalone
  - 5.2.1.2. Point of Care
5.3. Global Hematology Analyzers Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Hospitals
  - 5.3.1.2. Diagnostic Centers
  - 5.3.1.3. Ambulatory Surgical Centers
  - 5.3.1.4. Blood Banks
5.4. Global Hematology Analyzers Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. North America
  - 5.4.1.2. Europe
  - 5.4.1.3. Asia Pacific
  - 5.4.1.4. Latin America
  - 5.4.1.5. Middle East & Africa

6. North America Hematology Analyzers Market Outlook, 2018 - 2031

6.1. North America Hematology Analyzers Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. 3-Part
  - 6.1.1.2. 5-Part
  - 6.1.1.3. Others
6.2. North America Hematology Analyzers Market Outlook, by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Standalone
  - 6.2.1.2. Point of Care
6.3. North America Hematology Analyzers Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Hospitals
  - 6.3.1.2. Diagnostic Centers
  - 6.3.1.3. Ambulatory Surgical Centers
  - 6.3.1.4. Blood Banks
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. North America Hematology Analyzers Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. U.S. Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.4.1.2. U.S. Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.4.1.3. U.S. Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.4.1.4. Canada Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.4.1.5. Canada Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.4.1.6. Canada Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Hematology Analyzers Market Outlook, 2018 - 2031

7.1. Europe Hematology Analyzers Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. 3-Part
  - 7.1.1.2. 5-Part
  - 7.1.1.3. Others
7.2. Europe Hematology Analyzers Market Outlook, by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Standalone
  - 7.2.1.2. Point of Care
7.3. Europe Hematology Analyzers Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Hospitals
  - 7.3.1.2. Diagnostic Centers
  - 7.3.1.3. Ambulatory Surgical Centers
  - 7.3.1.4. Blood Banks
- 7.3.2. Attractiveness Analysis
7.4. Europe Hematology Analyzers Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Germany Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.2. Germany Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.3. Germany Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.4. U.K. Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.5. U.K. Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.6. U.K. Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.7. France Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.8. France Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.9. France Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.10. Italy Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.11. Italy Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.12. Italy Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.13. Turkey Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.14. Turkey Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.15. Turkey Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.16. Russia Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.17. Russia Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.18. Russia Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.19. Rest of Europe Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.20. Rest of Europe Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.21. Rest of Europe Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Hematology Analyzers Market Outlook, 2018 - 2031

8.1. Asia Pacific Hematology Analyzers Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. 3-Part
  - 8.1.1.2. 5-Part
  - 8.1.1.3. Others
8.2. Asia Pacific Hematology Analyzers Market Outlook, by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Standalone
  - 8.2.1.2. Point of Care
8.3. Asia Pacific Hematology Analyzers Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Hospitals
  - 8.3.1.2. Diagnostic Centers
  - 8.3.1.3. Ambulatory Surgical Centers
  - 8.3.1.4. Blood Banks
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Asia Pacific Hematology Analyzers Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. China Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.2. China Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.3. China Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.4. Japan Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.5. Japan Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.6. Japan Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.7. South Korea Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.8. South Korea Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.9. South Korea Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.10. India Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.11. India Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.12. India Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.13. Southeast Asia Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.14. Southeast Asia Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.15. Southeast Asia Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.16. Rest of Asia Pacific Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.17. Rest of Asia Pacific Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.18. Rest of Asia Pacific Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Hematology Analyzers Market Outlook, 2018 - 2031

9.1. Latin America Hematology Analyzers Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 9.1.1. Key Highlights
  - 9.1.1.1. 3-Part
  - 9.1.1.2. 5-Part
  - 9.1.1.3. Others
9.2. Latin America Hematology Analyzers Market Outlook, by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.3. Latin America Hematology Analyzers Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 9.3.1. Key Highlights
  - 9.3.1.1. Hospitals
  - 9.3.1.2. Diagnostic Centers
  - 9.3.1.3. Ambulatory Surgical Centers
  - 9.3.1.4. Blood Banks
- 9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Latin America Hematology Analyzers Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 9.4.1. Key Highlights
  - 9.4.1.1. Brazil Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.2. Brazil Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.3. Brazil Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.4. Mexico Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.5. Mexico Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.6. Mexico Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.7. Argentina Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.8. Argentina Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.9. Argentina Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.10. Rest of Latin America Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.11. Rest of Latin America Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.12. Rest of Latin America Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Hematology Analyzers Market Outlook, 2018 - 2031

10.1. Middle East & Africa Hematology Analyzers Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.1.1. Key Highlights
  - 10.1.1.1. 3-Part
  - 10.1.1.2. 5-Part
  - 10.1.1.3. Others
10.2. Middle East & Africa Hematology Analyzers Market Outlook, by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.2.1. Key Highlights
  - 10.2.1.1. Standalone
  - 10.2.1.2. Point of Care
10.3. Middle East & Africa Hematology Analyzers Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.3.1. Key Highlights
  - 10.3.1.1. Hospitals
  - 10.3.1.2. Diagnostic Centers
  - 10.3.1.3. Ambulatory Surgical Centers
  - 10.3.1.4. Blood Banks
- 10.3.2. BPS Analysis/Market Attractiveness Analysis
10.4. Middle East & Africa Hematology Analyzers Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.4.1. Key Highlights
  - 10.4.1.1. GCC Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.2. GCC Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.3. GCC Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.4. South Africa Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.5. South Africa Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.6. South Africa Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.7. Egypt Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.8. Egypt Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.9. Egypt Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.10. Nigeria Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.11. Nigeria Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.12. Nigeria Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.13. Rest of Middle East & Africa Hematology Analyzers Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.14. Rest of Middle East & Africa Hematology Analyzers Market by Modality, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.15. Rest of Middle East & Africa Hematology Analyzers Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

11.1. By End User vs by Modality Heatmap
11.2. Company Market Share Analysis, 2023
11.3. Competitive Dashboard
11.4. Company Profiles
- 11.4.1. SYSMEX CORPORATION
  - 11.4.1.1. Company Overview
  - 11.4.1.2. Product Portfolio
  - 11.4.1.3. Financial Overview
  - 11.4.1.4. Business Strategies and Development
- 11.4.2. Abbott Laboratories
  - 11.4.2.1. Company Overview
  - 11.4.2.2. Product Portfolio
  - 11.4.2.3. Financial Overview
  - 11.4.2.4. Business Strategies and Development
- 11.4.3. Beckman Coulter Inc
  - 11.4.3.1. Company Overview
  - 11.4.3.2. Product Portfolio
  - 11.4.3.3. Financial Overview
  - 11.4.3.4. Business Strategies and Development
- 11.4.4. Siemens AG
  - 11.4.4.1. Company Overview
  - 11.4.4.2. Product Portfolio
  - 11.4.4.3. Financial Overview
  - 11.4.4.4. Business Strategies and Development
- 11.4.5. Boule Diagnostics AB.
  - 11.4.5.1. Company Overview
  - 11.4.5.2. Product Portfolio
  - 11.4.5.3. Financial Overview
  - 11.4.5.4. Business Strategies and Development
- 11.4.6. Nihon Kohden Corporation
  - 11.4.6.1. Company Overview
  - 11.4.6.2. Product Portfolio
  - 11.4.6.3. Financial Overview
  - 11.4.6.4. Business Strategies and Development
- 11.4.7. Mindray
  - 11.4.7.1. Company Overview
  - 11.4.7.2. Product Portfolio
  - 11.4.7.3. Financial Overview
  - 11.4.7.4. Business Strategies and Development
- 11.4.8. HORIBA Ltd.
  - 11.4.8.1. Company Overview
  - 11.4.8.2. Product Portfolio
  - 11.4.8.3. Financial Overview
  - 11.4.8.4. Business Strategies and Development
- 11.4.9. Diatron
  - 11.4.9.1. Company Overview
  - 11.4.9.2. Product Portfolio
  - 11.4.9.3. Financial Overview
  - 11.4.9.4. Business Strategies and Development
- 11.4.10. Cellavision
  - 11.4.10.1. Company Overview
  - 11.4.10.2. Product Portfolio
  - 11.4.10.3. Financial Overview
  - 11.4.10.4. Business Strategies and Development

12. Appendix

12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations